The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
|
---|---|
Published in |
Cochrane database of systematic reviews, February 2013
|
DOI | 10.1002/14651858.cd002265.pub3 |
Pubmed ID | |
Authors |
Virginia Fernandes Moça Trevisani, Aldemar A Castro, João Ferreira Neves Neto, Álvaro N Atallah |
Abstract |
Neuropsychiatric involvement in systemic lupus erythematosus (SLE) is complex and it is an important cause of morbidity and mortality. Management of nervous system manifestations of SLE remains unsatisfactory. This is an update of a Cochrane review first published in 2000 and previously updated in 2006. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 1 | 33% |
Mauritius | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Unknown | 193 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 25 | 13% |
Researcher | 24 | 12% |
Student > Postgraduate | 21 | 11% |
Student > Bachelor | 18 | 9% |
Student > Doctoral Student | 15 | 8% |
Other | 45 | 23% |
Unknown | 47 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 105 | 54% |
Psychology | 9 | 5% |
Nursing and Health Professions | 8 | 4% |
Neuroscience | 7 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 1% |
Other | 13 | 7% |
Unknown | 51 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2022.
All research outputs
#7,408,361
of 26,409,992 outputs
Outputs from Cochrane database of systematic reviews
#8,718
of 13,223 outputs
Outputs of similar age
#56,457
of 207,078 outputs
Outputs of similar age from Cochrane database of systematic reviews
#131
of 208 outputs
Altmetric has tracked 26,409,992 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 13,223 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 208 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.